Results 301 to 310 of about 2,075,344 (349)
Some of the next articles are maybe not open access.
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.
New England Journal of Medicine, 2023BACKGROUND Osimertinib is a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) that is selective for EGFR-TKI-sensitizing and EGFR T790M resistance mutations.
D. Planchard +20 more
semanticscholar +1 more source
2023
Chemotherapy is a widely recognized form of cancer treatment that uses cytotoxic drugs to treat varieties of cancer. In general, these drugs intend to kill the cancer cell and stop the reproduction of cancer cells by which they can prevent further growth and spread.
Mahabuba Binta, Hossain +1 more
openaire +2 more sources
Chemotherapy is a widely recognized form of cancer treatment that uses cytotoxic drugs to treat varieties of cancer. In general, these drugs intend to kill the cancer cell and stop the reproduction of cancer cells by which they can prevent further growth and spread.
Mahabuba Binta, Hossain +1 more
openaire +2 more sources
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
New England Journal of Medicine, 2023BACKGROUND Amivantamab has been approved for the treatment of patients with advanced non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertions who have had disease progression during or after platinum-based ...
Caicun Zhou +27 more
semanticscholar +1 more source
Clinics in Plastic Surgery, 2000
The main use of systemic chemotherapy in metastatic melanoma remains palliative. Dacarbazine (dimethyl-1-triazeno imidazole-4-carboxamide [DTIC]) is the standard chemotherapy agent for advanced disease. The combination chemotherapy and biochemotherapy regimens have achieved higher response rates, but have not led to durable remission or improved ...
V M, Klimek +4 more
openaire +2 more sources
The main use of systemic chemotherapy in metastatic melanoma remains palliative. Dacarbazine (dimethyl-1-triazeno imidazole-4-carboxamide [DTIC]) is the standard chemotherapy agent for advanced disease. The combination chemotherapy and biochemotherapy regimens have achieved higher response rates, but have not led to durable remission or improved ...
V M, Klimek +4 more
openaire +2 more sources
Journal of the American Academy of Orthopaedic Surgeons, 2013
Sarcomas are a rare, heterogeneous group of malignant tumors of the bone or soft tissue. Although historically intended for the pharmaceutical treatment of microbes, today chemotherapy is used in orthopaedic oncology and is arguably the primary reason for improved survivorship.
Brian E, Walczak, Ronald B, Irwin
openaire +2 more sources
Sarcomas are a rare, heterogeneous group of malignant tumors of the bone or soft tissue. Although historically intended for the pharmaceutical treatment of microbes, today chemotherapy is used in orthopaedic oncology and is arguably the primary reason for improved survivorship.
Brian E, Walczak, Ronald B, Irwin
openaire +2 more sources
Angewandte Chemie International Edition, 2013
AbstractAfter malaria, schistosomiasis (or bilharzia) is the second most prevalent disease in Africa, and is occurring in over 70 countries in tropical and subtropical regions. It is estimated that 600 million people are at risk of infection, 200 million people are infected, and at least 200 000 deaths per year are associated with the disease.
Sophie A-L, Thétiot-Laurent +3 more
openaire +2 more sources
AbstractAfter malaria, schistosomiasis (or bilharzia) is the second most prevalent disease in Africa, and is occurring in over 70 countries in tropical and subtropical regions. It is estimated that 600 million people are at risk of infection, 200 million people are infected, and at least 200 000 deaths per year are associated with the disease.
Sophie A-L, Thétiot-Laurent +3 more
openaire +2 more sources
British Medical Bulletin, 1995
The overall median survival of patients with systemic metastasis from melanoma is about 6 months. Survival is dependent on the sites of first metastasis, the resectability of the metastases, and the number of metastases. Patients with non-visceral metastases at first relapse i.e.
S M, Lee, D C, Betticher, N, Thatcher
openaire +2 more sources
The overall median survival of patients with systemic metastasis from melanoma is about 6 months. Survival is dependent on the sites of first metastasis, the resectability of the metastases, and the number of metastases. Patients with non-visceral metastases at first relapse i.e.
S M, Lee, D C, Betticher, N, Thatcher
openaire +2 more sources
Cancer Chemotherapy and Pharmacology, 1987
A total of 85 cases treated by intravesical administration of adriamycin (ADM) at Okayama University and other cooperating institutions were examined. Instillation of 50 mg adriamycin dissolved in 30 ml physiological saline was performed in two courses of 3 consecutive days, with a 4-day interval between the courses.
T, Obama, Y, Matsumura, H, Ohmori
openaire +2 more sources
A total of 85 cases treated by intravesical administration of adriamycin (ADM) at Okayama University and other cooperating institutions were examined. Instillation of 50 mg adriamycin dissolved in 30 ml physiological saline was performed in two courses of 3 consecutive days, with a 4-day interval between the courses.
T, Obama, Y, Matsumura, H, Ohmori
openaire +2 more sources
Neurosurgery, 1995
In an effort to improve survival from malignant gliomas, investigators have used intratumoral chemotherapy protocols to deliver high doses of tumoricidal agents directly to the brain. Theoretically, these infusions bypass the blood-brain barrier, minimize systemic drug levels and the side effects of chemotherapy, and achieve prolonged elevations of ...
K A, Walter +4 more
openaire +2 more sources
In an effort to improve survival from malignant gliomas, investigators have used intratumoral chemotherapy protocols to deliver high doses of tumoricidal agents directly to the brain. Theoretically, these infusions bypass the blood-brain barrier, minimize systemic drug levels and the side effects of chemotherapy, and achieve prolonged elevations of ...
K A, Walter +4 more
openaire +2 more sources
Pediatric Annals, 1986
The above discussion is not intended to be exhaustive but rather to discuss several compounds which are particularly promising at this time. There is no question that great strides have been made in the development of antiviral compounds over the past couple of decades.
openaire +2 more sources
The above discussion is not intended to be exhaustive but rather to discuss several compounds which are particularly promising at this time. There is no question that great strides have been made in the development of antiviral compounds over the past couple of decades.
openaire +2 more sources